Gyrolab Spin Blog

Apr 6, 2020 8:18:21 PM

Enhancing the productivity of immunoassays: a 2-plex Gyrolab® assay for both preclinical and clinical studies

Target-specific reagents and immunoassay formats smoothen validation and transfer between CMC, preclinical, and clinical applications, and also to a CRO

Enhancing the productivity of immunoassays: a 2-plex Gyrolab assay for both preclinical and clinical studieRobust, accurate, precise, and time effective ligand binding assay platforms are crucial for the development of advanced bioassays for analyzing therapeutic antibody mixtures due to the inherent complexity of these drugs. This is why Symphogen A/S, Denmark chose Gyrolab system to develop assays to support chemistry, manufacturing, and controls (CMC) release and stability programs, and pharmacokinetics preclinical and clinical studies on Sym015, a novel anti-cancer biotherapeutic comprising two humanized monoclonal antibodies (mAbs).

Read More

Topics: Pharmacokinetics, Clinical trial, Preclinical studies, CRO transfer